News
Stand Up To Cancer Dream Team Collective Seeks to Transform Care of Gastroesophageal Cancer
March 2024
A collaboration between Dr. Jedd Wolchok, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, and Dr. Yelena Janjigian, chief of the gastrointestinal oncology service at Memorial Sloan Kettering Cancer Center, is looking to transform the care of gastroesophageal cancer (GEC) patients with untreatable disease – earning the pair a grant from Stand Up To Cancer® (SU2C) as a part of the SU2C-Torrey Coast Foundation Gastroesophageal Cancer Dream Team Collective.
Parker Institute for Cancer Immunotherapy (PICI) Welcomes Weill Cornell Medicine to Cancer Research Consortium
December 2023
The Parker Institute for Cancer Immunotherapy (PICI) announced it has added Weill Cornell Medicine to its network of preeminent academic and medical research institutions at the forefront of the fight against cancer.
Dr. Taha Merghoub and Dr. Jedd Wolchok won an ASPIRE Award from the Mark Foundation for Cancer Research
November 2023
Dr. Taha Merghoub, deputy director of the Sandra and Edward Meyer Cancer Center and Dr. Jedd Wolchok, the Meyer Director of the Meyer Cancer Center and a professor of medicine, won an ASPIRE Award from the Mark Foundation for Cancer Research. The awards support research in adult and pediatric cancers that aims to answer key feasibility and proof-of-concept questions in an accelerated timeframe.
Surprise Finding Shows That Neutrophils Can Be Key Antitumor Weapons
March 2023
In the study, published March 30 in Cell, the researchers investigated how a T cell-based immunotherapy was able to destroy melanoma tumors even though many of the tumor cells lacked the markers or “antigens” targeted by the T cells. They found that the T cells, in attacking the tumors, activated a swarm of neutrophils—which in turn killed the tumor cells that the T cells couldn’t eliminate. The findings could lead to new immunotherapies that harness this unexpected but potent antitumor immune response.
Dr. Jedd Wolchok Elected to the American Association for Cancer Research Board of Directors
March 2023
Dr. Jedd D. Wolchok, the Meyer Director of the Meyer Cancer Center and a professor of medicine, has been elected a member of the American Association for Cancer Research's Board of Directors. The association’s mission is to prevent and cure cancer through research, education, communication, collaboration, funding and advocacy. The association is the first and largest cancer research organization dedicated to accelerating the conquest of cancer.
Dr. Wolchok was one of five individuals elected for the 2023-2026 terms, with the mandate to work toward the AACR's mission of curing cancer.
Dr. Jedd Wolchok and Dr. Taha Merghoub Appointed Meyer Director and Deputy Director of the Sandra and Edward Meyer Cancer Center
July 2022
Dr. Jedd Wolchok, an internationally acclaimed medical oncologist whose innovations in immunotherapy have revolutionized melanoma treatment, has been recruited as the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, effective Sept. 12.
The institution has also appointed Dr. Taha Merghoub, a highly accomplished and innovative research scientist who has been Dr. Wolchok’s scientific partner at Memorial Sloan Kettering for over 15 years as well as a professor of immunology research in medicine at Weill Cornell Medicine, as deputy director of the Meyer Cancer Center.